Opgenorth Paul Hideo 4

What Happened Paul Hideo Opgenorth, Vice President, Development at Exozymes Inc. (EXOZ), was granted 3,999 shares on April 1, 2026. The reported acquisition price is $8.44 per share, for a total value of approximately $33,752. This was an award/other acquisition (Form 4 code A), meaning the insider received shares rather than buying them on the open market.

Key Details

• Transaction date: 2026-04-01
• Transaction type: Award / Grant (Form 4 code A)
• Shares acquired: 3,999 at $8.44 per share — total ≈ $33,752
• Filing date: 2026-04-08; no late-filing indicator was reported in the available data
• Shares owned after transaction: Not specified in the provided filing details
• Footnotes or special plans (e.g., 10b5-1, tax withholding): None reported in the summary provided

Context An award/grant is company compensation (not an open-market purchase or sale) and is commonly used for retention or incentive. Such grants signal alignment of the executive with shareholder interests but do not, by themselves, indicate a view on near-term stock direction. For full details, retail investors should review the complete Form 4 filing (Accession: 0001493152-26-015627) and any related company disclosures.